Tvardi Therapeutics Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Imran Alibhai
Chief executive officer
US$857.3k
Total compensation
| CEO salary percentage | 64.28% |
| CEO tenure | no data |
| CEO ownership | 1.3% |
| Management average tenure | 4.5yrs |
| Board average tenure | 1.4yrs |
Recent management updates
Recent updates
CEO
Imran Alibhai (49 yo)
Dr. Imran Alibhai, Ph D, serves as Chief Executive Officer and Director of Tvardi Therapeutics, Inc. He served as Senior Vice President of Business Development at DNAtrix, Inc until December 2018 and also...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | no data | US$857.33k | 1.31% $ 3.1m | |
| Founder | no data | no data | 0.16% $ 378.1k | |
| Chief Financial Officer | 2.8yrs | US$552.60k | 0.27% $ 643.3k | |
| Chief Medical Officer | 2.4yrs | US$565.83k | 0.15% $ 365.3k | |
| Co-Founder & Scientific Advisory Board Member | 8.5yrs | no data | 3.37% $ 8.0m | |
| Co-Founder & Chairman of Scientific Advisory Board | 8.5yrs | no data | 2.78% $ 6.6m | |
| Co-Founder & Scientific Advisory Board Member | no data | no data | no data | |
| Senior Vice President of R&D | 4.5yrs | no data | no data | |
| VP of Finance & Corporate Controller | no data | no data | no data | |
| Vice President of CMC | no data | no data | no data |
Experienced Management: TVRD's management team is considered experienced (4.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | no data | US$857.33k | 1.31% $ 3.1m | |
| Founder | no data | no data | 0.16% $ 378.1k | |
| Co-Founder & Scientific Advisory Board Member | no data | no data | 3.37% $ 8.0m | |
| Co-Founder & Chairman of Scientific Advisory Board | no data | no data | 2.78% $ 6.6m | |
| Co-Founder & Scientific Advisory Board Member | no data | no data | no data | |
| Independent Director | 4.3yrs | US$25.00k | 0.052% $ 123.4k | |
| Scientific Advisory Board Member | no data | no data | no data | |
| Chairman | 4.5yrs | US$25.00k | 0.066% $ 156.0k | |
| Scientific Advisory Board Member | 1.4yrs | no data | no data | |
| Independent Director | less than a year | no data | 0.020% $ 47.5k | |
| Independent Director | less than a year | no data | no data |
Experienced Board: TVRD's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/23 04:06 |
| End of Day Share Price | 2025/07/23 00:00 |
| Earnings | N/A |
| Annual Earnings | N/A |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Tvardi Therapeutics, Inc. is covered by 7 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Julian Harrison | BTIG |
| Steven Seedhouse | Cantor Fitzgerald & Co. |
| Debanjana Chatterjee | JonesTrading Institutional Services, LLC |